Linking a 10-Year Atherosclerotic Cardiovascular Disease Risk Score to New Cardiovascular Events in Stages 0–3 of Cardiovascular–Kidney–Metabolic Syndrome: Insights from the China Health and Retirement Longitudinal Study (CHARLS) - Scorecard - MDSpire
Advertisement
Linking a 10-Year Atherosclerotic Cardiovascular Disease Risk Score to New Cardiovascular Events in Stages 0–3 of Cardiovascular–Kidney–Metabolic Syndrome: Insights from the China Health and Retirement Longitudinal Study (CHARLS)
Clinical Scorecard: Linking a 10-Year Atherosclerotic Cardiovascular Disease Risk Score to New Cardiovascular Events in Stages 0–3 of Cardiovascular–Kidney–Metabolic Syndrome: Insights from the China Health and Retirement Longitudinal Study (CHARLS)
At a Glance
Category
Detail
Condition
Cardiovascular-Kidney-Metabolic Syndrome
Key Mechanisms
Integration of cardiovascular, renal, and metabolic dysfunction to assess disease risk.
Target Population
Chinese adults aged 45 years and older.
Care Setting
Nationwide cohort study using CHARLS data.
Key Highlights
ASCVD10 year score predicts cardiovascular events in CKM syndrome stages 0-3.
Dynamic changes in ASCVD risk scores correlate with clinical outcomes.
CHARLS provides a comprehensive dataset for assessing cardiometabolic risk.
Guideline-Based Recommendations
Diagnosis
Utilize the ASCVD10 year score for risk stratification in adults.
Management
Implement preventive measures based on ASCVD risk categories.
Monitoring & Follow-up
Track changes in ASCVD scores over time to assess risk evolution.
Risks
Identify individuals with high cumulative ASCVD scores for targeted interventions.
Patient & Prescribing Data
Adults aged 45 years and older in China.
Focus on managing metabolic disorders to reduce CVD risk.
Clinical Best Practices
Conduct regular assessments of ASCVD risk factors.
Encourage lifestyle modifications to mitigate cardiometabolic risks.
Utilize longitudinal data to inform clinical decision-making.